Commentary
The potential for artificial intelligence to transform healthcare: perspectives from international health leaders
Christina Silcox, Eyal Zimlichmann, Katie Huber, Neil Rowen, Robert Saunders, Mark McClellan, Charles N. Kahn III, Claudia A. Salzberg, & David W. Bates
2024
Read MoreJournal Article
Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities
An N. Massaro, MD, Beth Boyer, MPH, Mira Gill, MS, Dure Kim, PharmD, Matthew Laughon, MD, MPH, Michele Walsh, MD, Monica E. Lemmon, MD, Betsy Pilon, BA, and Gerri Baer, MD, on behalf of the Duke-Margolis/FDA Measuring Clinical Benefit in Neonatal RCTs Workshop Participants*
2024
Read MoreWhite Paper
Modernizing Medicare Risk Adjustment and Performance Measurement
Mark McClellan, Sara Debab, Frank McStay, Mark Japinga, and Rob Saunders
2024
Read MoreIssue Brief
Considerations for FDA’s New Advanced Pharmaceutical Manufacturing Programs
Stephen Colvill, Cameron Joyce, Thomas Roades, Gerrit Hamre
2024
Read More